Merck adds Paul Diaz to board of directors
Alpha Vantage · The Globe and Mail · · AI-summarised by FinFlash
Merck & Co. appointed Paul J. Diaz, managing partner at Cressey & Company, to its board of directors effective November 1, 2026. Diaz previously served as CEO of Myriad Genetics and Kindred Healthcare, bringing healthcare leadership experience that is expected to strengthen Merck's governance and strategic insight.
Understand the context
Published information may change. Summaries can contain errors; check the original source. Educational information only, not investment advice.